Opportunity Information: Apply for PAR 16 050
Apply for PAR 16 050
- The HHS-NIH11 in the education, health sector is offering a public funding opportunity titled "Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24 )" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394,.
- This funding opportunity was created on Dec 07, 2015 and posted on Dec 07, 2015.
- Applicants must submit their applications by Nov 17, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $800,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24) opportunity (Funding Opportunity Number PAR 16 050) is a discretionary federal grant program from the U.S. Department of Health and Human Services, National Institutes of Health (HHS-NIH11). It uses a cooperative agreement mechanism (U24), which generally means the project is not run as a hands-off grant; instead, the NIH expects active scientific and programmatic involvement during the award period. The purpose of this announcement is to fund a single Coordinating Center (CC) that will support and organize the work of the broader SCLC Consortium, with the Consortiums research focus spanning prevention, diagnosis, treatment, and understanding why and how SCLC becomes resistant to therapy.
At its core, the Coordinating Center is meant to function as the operational backbone for a multi-site research effort in small cell lung cancer, a disease known for aggressive behavior, early spread, and frequent development of treatment resistance. While individual research sites generate scientific data and pursue specific aims, the CC typically handles the cross-cutting infrastructure that makes the group function like a unified program rather than a collection of disconnected projects. In practical terms, that often includes coordinating communications among participating investigators, standardizing processes and timelines, organizing meetings and working groups, tracking milestones and deliverables, managing shared resources, and supporting consistent approaches to data collection and reporting. Because the FOA explicitly emphasizes prevention, diagnosis, treatment, and mechanisms of treatment resistance, the CC is positioned to help align and integrate Consortium activities across the full clinical and translational pipeline, from early detection and risk reduction through therapeutic studies and resistance biology.
The award is categorized under the NIH health and education activity area and is associated with CFDA numbers 93.393 and 93.394, which correspond to NIH cancer-related assistance programs. The maximum award amount listed is an award ceiling of $800,000, indicating the upper bound of annual or total support as defined by the announcement. The posting and creation dates were December 7, 2015, and the application deadline was November 17, 2016 (both the original and current closing dates are the same), so this specific solicitation reflects a defined historical competition window rather than an open-ended rolling opportunity.
Eligibility is broad and includes many types of U.S. organizations that commonly participate in NIH programs. Eligible applicants include state, county, and city or township governments; special district governments; and independent school districts. It also includes public and state-controlled institutions of higher education, private institutions of higher education, and a wide range of nonprofit entities (both those with and without 501(c)(3) status, as long as they are not institutions of higher education when applying under the nonprofit category). Tribal governments that are federally recognized, as well as other tribal organizations, are eligible, along with public housing authorities/Indian housing authorities. For-profit organizations are also eligible (other than small businesses), and small businesses are explicitly listed as eligible as well. The listing also includes an "Others" category with a note to consult the FOA text for any additional eligibility clarifications, which is typical when NIH wants to accommodate specialized entities or partnerships.
Overall, this FOA is best understood as NIH seeking a dedicated team with strong project management, consortium coordination, and biomedical research administration experience to keep a national SCLC research network synchronized and productive. Rather than funding another standalone research project, the U24 Coordinating Center is meant to enable the larger Consortium to move faster and more coherently by ensuring consistent operations, shared standards, and centralized coordination in support of advances in SCLC prevention, diagnosis, treatment development, and understanding and overcoming treatment resistance.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled The Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PAR 16 050.
Which federal agency is offering this opportunity?
This is a discretionary federal grant program from the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH) (listed as HHS-NIH11).
What type of award mechanism is used?
The FOA uses a cooperative agreement mechanism (U24).
What does a U24 cooperative agreement generally mean for how the project is run?
A U24 generally indicates the project is not managed as a hands-off grant. Instead, NIH expects active scientific and programmatic involvement during the award period.
What is the main purpose of this funding announcement?
The purpose is to fund a single Coordinating Center (CC) that will support, organize, and coordinate the work of the broader SCLC Consortium.
How many Coordinating Centers will be funded under this announcement?
The announcement is intended to fund one Coordinating Center.
What is the overall research focus of the SCLC Consortium supported by this Coordinating Center?
The Consortium focus spans prevention, diagnosis, treatment, and understanding why and how small cell lung cancer becomes resistant to therapy.
What role does the Coordinating Center play within a multi-site consortium?
The Coordinating Center is described as the operational backbone for a multi-site research effort. While individual sites generate scientific data and pursue specific aims, the CC supports the cross-cutting infrastructure needed for the Consortium to function as a unified program.
What kinds of coordinating activities are typically handled by the Coordinating Center?
Based on the description provided, typical CC activities may include: coordinating communications among investigators; standardizing processes and timelines; organizing meetings and working groups; tracking milestones and deliverables; managing shared resources; and supporting consistent approaches to data collection and reporting.
Is this award intended to fund a standalone research project?
No. The U24 Coordinating Center is framed as support infrastructure to enable and synchronize the larger Consortium, rather than funding another independent, standalone research project.
How does the FOA position the Coordinating Center across the research pipeline?
Because the FOA emphasizes prevention, diagnosis, treatment, and mechanisms of resistance, the Coordinating Center is positioned to help align and integrate activities across the clinical and translational pipeline, from early detection and risk reduction through therapeutic studies and resistance biology.
What activity area is this opportunity categorized under?
The award is categorized under the NIH health and education activity area.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA 93.393 and CFDA 93.394, described as NIH cancer-related assistance programs.
What is the maximum award amount listed?
The maximum award amount listed is an award ceiling of $800,000, described as the upper bound of support as defined by the announcement.
When was this opportunity posted and created?
The posting date and creation date are both December 7, 2015.
What was the application deadline for this opportunity?
The application deadline was November 17, 2016. The original and current closing dates are the same.
Is this opportunity currently open for applications?
Based on the information provided, this solicitation reflects a defined historical competition window with a closing date of November 17, 2016, rather than an open-ended rolling opportunity.
Who is eligible to apply?
Eligibility is broad and includes many U.S. organization types commonly participating in NIH programs, including governments, higher education institutions, nonprofits, tribal entities, public housing authorities/Indian housing authorities, and for-profit entities (including small businesses).
Are state, local, and special district governments eligible?
Yes. Eligible applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.
Are colleges and universities eligible?
Yes. Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education.
Are nonprofits eligible to apply?
Yes. Eligibility includes a wide range of nonprofit entities, including nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status, as long as they are not institutions of higher education when applying under the nonprofit category.
Are tribal governments and tribal organizations eligible?
Yes. Eligible applicants include federally recognized tribal governments as well as other tribal organizations.
Are public housing authorities/Indian housing authorities eligible?
Yes. Public housing authorities/Indian housing authorities are explicitly listed as eligible.
Are for-profit organizations eligible?
Yes. For-profit organizations are eligible, and small businesses are also explicitly listed as eligible.
Does the eligibility list include an "Other" category?
Yes. The listing includes an "Others" category with a note to consult the FOA text for additional eligibility clarifications.
What kind of team is NIH seeking for the Coordinating Center?
The FOA is described as seeking a dedicated team with strong project management, consortium coordination, and biomedical research administration experience to keep a national SCLC research network synchronized and productive.
What disease area does this opportunity focus on?
The focus is small cell lung cancer (SCLC), described as aggressive, prone to early spread, and frequently developing treatment resistance.
What is meant by the Coordinating Center helping the Consortium move "faster and more coherently"?
As described, the Coordinating Center is intended to enable faster, more coherent progress by ensuring consistent operations, shared standards, and centralized coordination across the Consortium in support of advances in SCLC prevention, diagnosis, treatment development, and understanding and overcoming treatment resistance.
Browse more opportunities from the same category: Education, Health
Next opportunity: Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp)
Previous opportunity: Academic Units for Primary Care Training and Enhancement
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 050
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 050) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) Apply for RFA CA 16 002 Funding Number: RFA CA 16 002 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $300,000 |
| Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) Apply for RFA CA 16 004 Funding Number: RFA CA 16 004 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $300,000 |
| Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01) Apply for PAR 16 049 Funding Number: PAR 16 049 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $450,000 |
| Genomic Data Analysis Network: Processing Genomic Data Center (U24) Apply for RFA CA 15 018 Funding Number: RFA CA 15 018 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $660,000 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33) Apply for RFA NS 16 013 Funding Number: RFA NS 16 013 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $250,000 |
| Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer (U01) Apply for PAR 16 051 Funding Number: PAR 16 051 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $450,000 |
| Examination of Survivorship Care Planning Efficacy and Impact (R01) Apply for PA 16 012 Funding Number: PA 16 012 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Proteome Characterization Centers for Clinical Proteomic Tumor Analysis Consortium (U24) Apply for RFA CA 15 021 Funding Number: RFA CA 15 021 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $800,000 |
| Innovative Questions in Symptom Science and Genomics (R15) Apply for PA 16 022 Funding Number: PA 16 022 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $300,000 |
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01) Apply for PA 16 035 Funding Number: PA 16 035 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Drug Discovery For Nervous System Disorders (R21) Apply for PAR 16 042 Funding Number: PAR 16 042 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Revision Applications for Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (U10) Apply for PAR 16 056 Funding Number: PAR 16 056 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $150,000 |
| Innovative Questions in Symptom Science and Genomics (R01) Apply for PA 16 024 Funding Number: PA 16 024 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21) Apply for PAR 16 052 Funding Number: PAR 16 052 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $125,000 |
| Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (R01) Apply for RFA DA 16 011 Funding Number: RFA DA 16 011 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Innovative Questions in Symptom Science and Genomics (R21) Apply for PA 16 023 Funding Number: PA 16 023 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Apply for PAR 16 059 Funding Number: PAR 16 059 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $450,000 |
| Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01) Apply for PA 16 030 Funding Number: PA 16 030 Agency: HHS-NIH11 Category: Education, Health Funding Amount: Case Dependent |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) Apply for RFA CA 16 001 Funding Number: RFA CA 16 001 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
| Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21) Apply for PA 16 029 Funding Number: PA 16 029 Agency: HHS-NIH11 Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 050", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.